- Home
- INM vs ENVB Comparison
INM vs ENVB Comparison
Compare INM & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- ENVB
- Stock Information
- Founded
- INM 1981
- ENVB 1994
- Country
- INM Canada
- ENVB United States
- Employees
- INM N/A
- ENVB N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- ENVB Health Care
- Exchange
- INM Nasdaq
- ENVB Nasdaq
- Market Cap
- INM 3.2M
- ENVB 3.1M
- IPO Year
- INM N/A
- ENVB N/A
- Fundamental
- Price
- INM $3.09
- ENVB $1.22
- Analyst Decision
- INM
- ENVB Strong Buy
- Analyst Count
- INM 0
- ENVB 1
- Target Price
- INM N/A
- ENVB $10.00
- AVG Volume (30 Days)
- INM 9.5M
- ENVB 186.3K
- Earning Date
- INM 05-12-2025
- ENVB 08-11-2025
- Dividend Yield
- INM N/A
- ENVB N/A
- EPS Growth
- INM N/A
- ENVB N/A
- EPS
- INM N/A
- ENVB N/A
- Revenue
- INM $4,920,990.00
- ENVB N/A
- Revenue This Year
- INM N/A
- ENVB N/A
- Revenue Next Year
- INM N/A
- ENVB N/A
- P/E Ratio
- INM N/A
- ENVB N/A
- Revenue Growth
- INM N/A
- ENVB N/A
- 52 Week Low
- INM $1.72
- ENVB $1.01
- 52 Week High
- INM $15.70
- ENVB $11.55
- Technical
- Relative Strength Index (RSI)
- INM 51.86
- ENVB 40.62
- Support Level
- INM $3.32
- ENVB $1.19
- Resistance Level
- INM $5.50
- ENVB $1.32
- Average True Range (ATR)
- INM 0.37
- ENVB 0.07
- MACD
- INM 0.06
- ENVB 0.01
- Stochastic Oscillator
- INM 24.69
- ENVB 17.65
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.